Prevalence, one-year-incidence and predictors of carcinoid heart disease. [PDF]
Cardiovasc Ultrasound, 2023 Background Carcinoid heart disease (CHD) caused by neuroendocrine tumours (NET) is associated with an increased morbidity and mortality due to valvular dysfunction and right sided heart failure.
Mattig I +6 more
europepmc +2 more sources
Bioprosthetic valve monitoring in patients with carcinoid heart disease. [PDF]
Front Cardiovasc Med, 2022 Background Carcinoid heart disease (CnHD) is a frequent cause of morbidity and mortality in patients with neuroendocrine tumors and carcinoid syndrome. Although valve replacement surgery appears to decrease all-cause mortality in patients with advanced ...
Honan KA +21 more
europepmc +2 more sources
The Value of Repeat 5-HIAA Measurements as a Predictor of Carcinoid Heart Disease: A Prospective 5-Year Follow-Up Study in Patients with Small Intestinal Neuroendocrine Tumors. [PDF]
Cancers (Basel)Simple Summary Small intestinal neuroendocrine tumors (SI-NETs) can lead to carcinoid syndrome and carcinoid heart disease (CHD). In this prospective study we aimed to identify early risk markers for CHD and mortality in patients with SI-NETs.
Kostiainen I +8 more
europepmc +2 more sources
Quadruple Valve Replacement in Carcinoid Heart Disease: A Case Report. [PDF]
Cureus, 2023 This report details a rare case of left-sided carcinoid heart disease (CHD). In CHD, vasoactive substances released from carcinoid tumors cause fibrous tissue formation on the right side of the heart. These substances are usually inactivated by monoamine
Beyer M, Kasarla R, Shoap S, Beyer E.
europepmc +2 more sources
Acta Médica Portuguesa, 2017 The carcinoid syndrome is rare but it is associated with carcinoid heart disease in more than a half of the cases. Carcinoid heart disease is typically characterised by morphological and functional modifications of right-sided valves.
Joana Simões-Pereira +3 more
doaj +3 more sources
Ablation of typical atrial flutter as therapeutic component in carcinoid heart disease: a case report [PDF]
Journal of Medical Case Reports, 2022 Background Carcinoid heart disease is the cardiac manifestation of carcinoid syndrome. There is limited research on rhythm management in patients with carcinoid heart disease.
Susann Groschke +6 more
doaj +2 more sources
Molecular biology of carcinoid heart disease: Seeking therapeutic targets in the era of targeted therapy. [PDF]
Medicine (Baltimore), 2023 Carcinoid tumors (CT) are among the least studied tumors. It is a relatively rare and slow-growing tumor with good survival in its primary form. However, metastatic carcinoid tumor comes up with many different complications contributing to increased ...
Khan SA +6 more
europepmc +2 more sources
Metastatic well differentiated serotonin-producing pancreatic neuroendocrine tumor with carcinoid heart disease: a case report. [PDF]
J Gastrointest Oncol, 2023 Background Less than two percent of pancreatic neuroendocrine tumors (NETs) produce serotonin. Serotonin can cause carcinoid syndrome and less commonly carcinoid heart disease (CHD).
Kudelka MR +10 more
europepmc +2 more sources
Analysis of Patients with NET G1/G2 Neuroendocrine Tumors of the Small Intestine in the Course of Carcinoid Heart Disease-A Retrospective Study. [PDF]
J Clin Med, 2023 Neuroendocrine neoplasms of the small intestine (SI-NENs) are one of the most commonly recognized gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs).
Konsek-Komorowska SJ +6 more
europepmc +2 more sources
The Role of Transthoracic Echocardiography for Assessment of Mortality in Patients with Carcinoid Heart Disease Undergoing Valve Replacement. [PDF]
Cancers (Basel), 2023 Simple Summary A proportion of patients with neuroendocrine tumours develop carcinoid syndrome and subsequent carcinoid heart disease (CHD). Valve replacement is indicated for patients with CHD when there is severe regurgitation and symptoms or evidence ...
Brooke A +9 more
europepmc +2 more sources